. Author manuscript; available in PMC: 2020 Oct 1.

Published in final edited form as: J AAPOS. 2019 Sep 12;23(5):264.e1–264.e4. doi: 10.1016/j.jaapos.2019.05.014

Table 1.

Demographics of patients with aggressive posterior retinopathy at the Aravind Eye Hospital, Coimbatore, 2002–2018

Study parameter	Treatment group^a		P value
Study parameter	Laser (n = 84; 168 eyes)	Anti-VEGF (n = 115; 230 eyes)	P value
BW, g	1532 ± 363	1298 ± 371	<0.001
GA, weeks	31.5 ± 2.1	30.1 ± 2.7	<0.001
Sex, no. (% male)	51 (61)	78 (68)	0.3
Days on oxygen prior to diagnosis	9.8 ± 8.3	13.8 ± 14.7	0.01
PMA at first exam, weeks	34.1 ± 2.2	34.6 ± 2.6	0.19
PNA at first exam, weeks	2.7 ± 1.5	4.4 ± 1.7	<0.001
PMA at treatment, weeks	35.6 ± 2.2	35.0 ± 2.6	0.06
PNA at treatment, weeks	4.1 ± 1.4	4.8 ± 1.7	0.001
No. eyes with RD (%)	17 (10)	3 (1)	0.002

BW, birth weight; GA, gestational age; PMA, postmenstrual age; PNA, postnatal age; RD, retinal detachment.

All values mean with standard deviation except as noted.